Clinical Accelerator to Attend and Participate in PCR London Valves 2024
Nikolai "Nik" Nikitin, MD, PhD
President and Founder at Clinical Accelerator
Clinical Accelerator, a leading clinical trial management organization specializing in medical device studies, is excited to announce its attendance at the upcoming PCR London Valves conference, taking place from November 24-26, 2024. The event, a premier global gathering for the structural heart disease community, will be held at ExCeL London and is expected to bring together leading experts, clinicians, and innovators in the field of cardiovascular intervention.
Nik Nikitin to Participate in “Innovating Medtech” Session
Nik Nikitin, Managing Director of Clinical Accelerator, will be an active participant in this year's conference. On Monday, November 25th, Nikitin will join the session “Turning Your Idea into a Market-Ready Device – Innovating Medtech” as a discussant. This session will focus on guiding MedTech innovators through the complex process of transforming a concept into a market-ready device, with insights on navigating regulatory challenges, clinical validation, and scaling for market success. Dr Nikitin brings years of expertise in managing early-stage clinical trials for innovative devices and will share valuable perspectives on EFS trial execution, patient recruitment, and data quality.
领英推荐
About PCR London Valves
PCR London Valves is recognized as one of the foremost conferences dedicated to the latest innovations and best practices in valvular heart disease treatment. The event offers a rich program of presentations, live cases, hands-on workshops, and interactive sessions, fostering collaboration and knowledge-sharing among professionals in interventional cardiology and structural heart intervention. Key topics include transcatheter aortic valve replacement (TAVR), transcatheter mitral valve interventions, and advancements in imaging and procedural techniques.
About Clinical Accelerator
Clinical Accelerator is a full-service, academically affiliated clinical trial management organization, operating in Central and Eastern Europe and Central Asia. The company specializes in early-stage First-In-Human (FIH) and Early Feasibility Studies (EFS), with a strong emphasis on timely patient enrollment and rigorous data collection. Through well-executed clinical trials, Clinical Accelerator is committed to advancing innovative medical technologies that address critical unmet medical needs and improve patient care.
Clinical Accelerator looks forward to connecting with fellow professionals and industry leaders at PCR London Valves, contributing to discussions on the future of structural heart disease treatment, and supporting the development of groundbreaking medical technologies.